{"transactions":[{"id":732103,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Convertible Non-Redeemable Preferred Stock","published_at":"2026-06-18T20:30:31.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Non-Redeemable Preferred Stock (\"Series A Preferred Stock\") automatically converted into 8,128.1 shares of common stock, for no additional consideration, at 5 p. m. Eastern Time on June 16, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series A Convertible Non-Redeemable Preferred Stock of Azitra, Inc. (the \"Certificate of Designations\") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series A Preferred Stock was sold together with a Series B Common Stock Purchase Warrant to purchase shares of common stock and a Series C Common Stock Purchase Warrant to purchase shares of common stock (collectively, a \"Security\"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Non-Redeemable Preferred Stock (\"Series A Preferred Stock\") automatically converted into 8,128.1 shares of common stock, for no additional consideration, at 5 p. m. Eastern Time on June 16, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series A Convertible Non-Redeemable Preferred Stock of Azitra, Inc. (the \"Certificate of Designations\") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series A Preferred Stock was sold together with a Series B Common Stock Purchase Warrant to purchase shares of common stock and a Series C Common Stock Purchase Warrant to purchase shares of common stock (collectively, a \"Security\"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Non-Redeemable Preferred Stock (\"Series A Preferred Stock\") automatically converted into 8,128.1 shares of common stock, for no additional consideration, at 5 p. m. Eastern Time on June 16, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series A Convertible Non-Redeemable Preferred Stock of Azitra, Inc. (the \"Certificate of Designations\") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series A Preferred Stock was sold together with a Series B Common Stock Purchase Warrant to purchase shares of common stock and a Series C Common Stock Purchase Warrant to purchase shares of common stock (collectively, a \"Security\"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Non-Redeemable Preferred Stock (\"Series A Preferred Stock\") automatically converted into 8,128.1 shares of common stock, for no additional consideration, at 5 p. m. Eastern Time on June 16, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series A Convertible Non-Redeemable Preferred Stock of Azitra, Inc. (the \"Certificate of Designations\") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series A Preferred Stock was sold together with a Series B Common Stock Purchase Warrant to purchase shares of common stock and a Series C Common Stock Purchase Warrant to purchase shares of common stock (collectively, a \"Security\"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4064050},"source":{"system":"sec-edgar","filing":"0001493152-26-029345","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226029345/ownership.xml","form_type":"4"}},{"id":732102,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-06-18T20:30:31.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":4064050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Non-Redeemable Preferred Stock (\"Series A Preferred Stock\") automatically converted into 8,128.1 shares of common stock, for no additional consideration, at 5 p. m. Eastern Time on June 16, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series A Convertible Non-Redeemable Preferred Stock of Azitra, Inc. (the \"Certificate of Designations\") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series A Preferred Stock was sold together with a Series B Common Stock Purchase Warrant to purchase shares of common stock and a Series C Common Stock Purchase Warrant to purchase shares of common stock (collectively, a \"Security\"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,241 Incentive Stock Options held by Mr. Salva and exercisable within 60 days of June 16, 2026."}],"balance_after":4086291,"source":{"system":"sec-edgar","filing":"0001493152-26-029345","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226029345/ownership.xml","form_type":"4"}},{"id":802840,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (Right To Buy)","published_at":"2026-04-22T21:30:00.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":220879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total number of shares of the Company's common stock subject to the option shall vest on the one year anniversary of the date of issuance, the Vesting Commencement Date, and 1/36th of the total number of shares of the Company's common stock subject to the option will vest each calendar month thereafter for the next two years, on the same day of the month as the Vesting Commencement Date."}],"balance_after":220879,"derivative":{"exercise_price":0.2127,"expiration_date":"2036-04-20","underlying":"Common Stock","underlying_shares":220879},"source":{"system":"sec-edgar","filing":"0001493152-26-018596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226018596/ownership.xml","form_type":"4"}},{"id":832334,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series C Warrants","published_at":"2026-03-20T20:30:30.000Z","date":"2026-03-18","kind":"purchase","planned":false,"acquired":true,"shares":4064050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Warrants are exercisable upon stockholder approval and will terminate, subject to certain exceptions, upon the 30th calendar day following the date on which Azitra, Inc. publicly announces data from its planned human cosmetic study testing the effect of the filaggrin technology."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Warrants are exercisable upon stockholder approval and will terminate, subject to certain exceptions, upon the 30th calendar day following the date on which Azitra, Inc. publicly announces data from its planned human cosmetic study testing the effect of the filaggrin technology."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Warrants are exercisable upon stockholder approval and will terminate, subject to certain exceptions, upon the 30th calendar day following the date on which Azitra, Inc. publicly announces data from its planned human cosmetic study testing the effect of the filaggrin technology."}],"balance_after":4064050,"derivative":{"exercise_price":0.123,"underlying":"Common Stock","underlying_shares":4064050},"source":{"system":"sec-edgar","filing":"0001493152-26-011858","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226011858/ownership.xml","form_type":"4"}},{"id":832333,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series B Warrants","published_at":"2026-03-20T20:30:30.000Z","date":"2026-03-18","kind":"purchase","planned":false,"acquired":true,"shares":4064050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock has stated value of $1,000.00 per share. Each share of Series A Preferred Stock automatically converts into 8,128.1 shares of Common Stock, subject to adjustment from time to time in accordance with its Certificate of Designations, Preferences, as of 5:00 p.m. Eastern time on the 1st business day after the date that the Issuer's stockholders have approved each of (A) an increase in the number of authorized shares of the Issuer's Common Stock to enable the Issuer to issue all of the shares of Common Stock that are issuable upon the conversion of the Series A Preferred Stock and (B) the conversion of the Series A Preferred Stock into Common Stock in accordance with the listing rules of the applicable trading market, and subject to the Issuer filing an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware evidencing such stockholder approval. The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Warrants are exercisable upon stockholder approval and will terminate 18 months following the date of stockholder approval."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Warrants are exercisable upon stockholder approval and will terminate 18 months following the date of stockholder approval."}],"balance_after":4064050,"derivative":{"exercise_price":0.123,"underlying":"Common Stock","underlying_shares":4064050},"source":{"system":"sec-edgar","filing":"0001493152-26-011858","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226011858/ownership.xml","form_type":"4"}},{"id":832332,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Convertible Non-Redeemable Preferred Stock","published_at":"2026-03-20T20:30:30.000Z","date":"2026-03-18","kind":"purchase","planned":false,"acquired":true,"shares":500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock has stated value of $1,000.00 per share. Each share of Series A Preferred Stock automatically converts into 8,128.1 shares of Common Stock, subject to adjustment from time to time in accordance with its Certificate of Designations, Preferences, as of 5:00 p.m. Eastern time on the 1st business day after the date that the Issuer's stockholders have approved each of (A) an increase in the number of authorized shares of the Issuer's Common Stock to enable the Issuer to issue all of the shares of Common Stock that are issuable upon the conversion of the Series A Preferred Stock and (B) the conversion of the Series A Preferred Stock into Common Stock in accordance with the listing rules of the applicable trading market, and subject to the Issuer filing an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware evidencing such stockholder approval. The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock has stated value of $1,000.00 per share. Each share of Series A Preferred Stock automatically converts into 8,128.1 shares of Common Stock, subject to adjustment from time to time in accordance with its Certificate of Designations, Preferences, as of 5:00 p.m. Eastern time on the 1st business day after the date that the Issuer's stockholders have approved each of (A) an increase in the number of authorized shares of the Issuer's Common Stock to enable the Issuer to issue all of the shares of Common Stock that are issuable upon the conversion of the Series A Preferred Stock and (B) the conversion of the Series A Preferred Stock into Common Stock in accordance with the listing rules of the applicable trading market, and subject to the Issuer filing an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware evidencing such stockholder approval. The Series A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock has stated value of $1,000.00 per share. Each share of Series A Preferred Stock automatically converts into 8,128.1 shares of Common Stock, subject to adjustment from time to time in accordance with its Certificate of Designations, Preferences, as of 5:00 p.m. Eastern time on the 1st business day after the date that the Issuer's stockholders have approved each of (A) an increase in the number of authorized shares of the Issuer's Common Stock to enable the Issuer to issue all of the shares of Common Stock that are issuable upon the conversion of the Series A Preferred Stock and (B) the conversion of the Series A Preferred Stock into Common Stock in accordance with the listing rules of the applicable trading market, and subject to the Issuer filing an amendment to the Certificate of Incorporation with the Secretary of State of the State of Delaware evidencing such stockholder approval. The Series A Preferred Stock has no expiration date."}],"balance_after":500,"derivative":{"exercise_price":0.123,"underlying":"Common Stock","underlying_shares":4064050},"source":{"system":"sec-edgar","filing":"0001493152-26-011858","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315226011858/ownership.xml","form_type":"4"}},{"id":960999,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (Right To Buy)","published_at":"2025-12-22T22:28:26.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":59309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares of the Company's Common Stock subject to the Option shall vest on the date of issuance, the Vesting Commencement Date, and the remaining balance shall vest in equal monthly installments over the next 36 months of continuous service thereafter."}],"balance_after":59309,"derivative":{"exercise_price":0.2968,"expiration_date":"2035-12-19","underlying":"Common Stock","underlying_shares":59309},"source":{"system":"sec-edgar","filing":"0001493152-25-028846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315225028846/ownership.xml","form_type":"4"}},{"id":1500515,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-28T16:38:10.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 23, 2025, the next annual meeting of stockholders, or the consummation of a change of control, subject to the director's continued service."}],"balance_after":15000,"derivative":{"exercise_price":0.7036,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-065295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000095017024065295/ownership.xml","form_type":"4"}},{"id":1640995,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-16T01:38:23.000Z","date":"2024-02-13","kind":"purchase","planned":false,"acquired":true,"shares":333300,"price":0.3,"value":99990.0,"ownership":{"direct":true},"balance_after":338300,"source":{"system":"sec-edgar","filing":"0001493152-24-006912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315224006912/ownership.xml","form_type":"4"}},{"id":1845247,"issuer":{"id":7959,"kind":"organization","name":"Azitra, Inc."},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-24T00:39:16.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":5,"value":25000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001493152-23-022316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701478/000149315223022316/ownership.xml","form_type":"4"}},{"id":1874976,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T16:05:32.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 25, 2024, the next annual meeting of stockholders, or the consummation of a change of control, subject to the director's continued service."}],"balance_after":15000,"derivative":{"exercise_price":1.62,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-23-014050","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924323014050/doc4.xml","form_type":"4"}},{"id":2251543,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-31T16:06:13.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 26, 2023, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":15000,"derivative":{"exercise_price":1.61,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-020151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924322020151/doc4.xml","form_type":"4"}},{"id":2712523,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T17:23:02.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of May 13, 2022, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":20000,"derivative":{"exercise_price":16.34,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-019558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924321019558/doc4.xml","form_type":"4"}},{"id":2931530,"issuer":{"id":84409,"kind":"organization","name":"Vincerx Pharma, Inc.","symbol":"VINC"},"owners":[{"id":36820,"kind":"person","name":"Salva Francisco D.","position":1,"cik":"0001834051","reported_name":"Salva Francisco D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-28T21:26:01.000Z","date":"2020-12-23","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of December 23, 2021, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service."}],"balance_after":6667,"derivative":{"exercise_price":19,"expiration_date":"2030-12-23","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0000899243-20-035390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796129/000089924320035390/doc4.xml","form_type":"4"}}]}